Biotronik Inlexa implantable cardioverter defibrillator

Country: Singapore

Language: English

Source: HSA (Health Sciences Authority)

Available from:

BIOTRONIK ASIA PACIFIC PTE. LTD.

Class:

Class D medical device

Manufactured by:

BIOTRONIK SE & Co. KG

Therapeutic area:

Cardiovascular

Therapeutic indications:

Biotronik implantable cardioverter defibrillators (ICDs) are intended to treat life-threatening ventricular arrhythmias with antitachycardia pacing and defibrillation

Product summary:

Device System Info:[Sterile Medical Device], EO sterilized; Models: BS IS-1 - 330834, BS DF-1 - 119602, BS IS4 - 403724, Inlexa 3 VR-T - 404703, Inlexa 7 VR-T DX - 404642, Inlexa 3 DR-T - 404701, Inlexa 3 HF-T - 404699, Inlexa 3 HF-T QP - 416037, Inlexa 3 VR-T DF4 - 404704, Inlexa 3 DR-T DF4 - 404702, Inlexa 3 HF-T DF4 - 404700, Inlexa 3 HF-T QP DF4 - 416038, Inlexa 7 VR-T - 404643, Inlexa 7 DR-T - 404640, Inlexa 7 HF-T - 404636, Inlexa 7 VR-T DF4 - 404644, Inlexa 7 DR-T DF4 - 404641, Inlexa 7 HF-T DF4 - 404637, Inlexa 7 HF-T QP IS4 - 404638, Inlexa 7 HF-T QP DF4/IS4 - 404639

Authorization date:

2018-08-10